ArticleJournal of Cancer2019

Tumoral Pyruvate Kinase L/R as a Predictive Marker for the Treatment of Renal Cancer Patients with Sunitinib and Sorafenib.

Marjut Niinivirta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.